Susan Acker-Walsh joined the Clinipace team in 2015, where she is currently the chief operating officer. Her 30-year clinical research career has allowed her to launch complex business initiatives and bring them to fruition, creating new businesses and developing several companies into major players in their market space.
Before joining Clinipace, Acker-Walsh served as president and COO at SciMetrika and spent 13 years with SRA International as vice president and director of health and civilian government. She joined SRA via acquisition where she played an instrumental part in the complex integration of Constella Group into SRA’s new global health sector. She was retained to help lead this effort after serving integral roles on Constella Group’s executive leadership team as senior vice president of corporate, organization and people development and as the corporate compliance officer.